プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Gloria V.に依頼

Switzerland

Pre-Clinical/Clinical Project Manager & Scientific Writer | 15 years experience in multidisciplinary R&D

プロフィール概要

CV • Progressed from fundamental multidisciplinary research (Chemistry, Nanobiotech, Biochemistry) to in vitro Pharmacology (Cell Biology, Target ID, Proteomics), moving to Pharmaceutical R&D (ADME/DMPK) and getting into Project Management and Clinical trial OP, with a last immersion into the Medical Device Development. • This has provided me with a deep knowledge in a variety of scientific and clinical fields, as well as a broad understanding of the drug development process from bench to market and beyond. • My fluency in four languages (English, German, Spanish, Catalan) combined with my international career (Spain, Germany, Switzerland) in multicultural environments allows me to write for a diversity of public. Fields of expertise • Clinical research: - Therapeutic areas: Oncology, Immunology, Rheumatology, Neurodegenerative disorders - Phase I/II including first-in-human (monitoring, reporting, data management) - In vitro to human ADME Pharmacokinetics (bioanalysis) - Regulatory: Knowledge of good practices (GRP/GLP/GCP), clinical guidelines (ICH, FDA, EMA). • Pre-clinical research: in vitro Pharmacology, Cell Biology, Target Identification and Validation, High Throughput Screening, Proteomics, in vitro Toxicology, DMPK, Bioanalysis, Medicinal Chemistry. • Biotech research: Biosensor development, compound and antibody labelling, diagnostic tools, Quantum Dots, Nanoparticle-based biosensors, ELISA

専門分野

• ★ Preclinical Research
• ★ Clinical Trials
• ★ Research
• ☆ Organic Chemistry
• ☆ Biology/Life Sciences
• ☆ Proteomics
• ☆ Nanobiotechnology
• ☆ Chemical Biology
• ☆ Medicinal Chemistry
• ☆ Medical Devices
• ☆ Clinical Biochemistry
• ☆ Regulatory Writing
• ☆ Medical Writing

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Technical Writing, Copywriting, Newswriting

Research Market Research, User Research, Meta-Research, Feasibility Study, Fact Checking, Gap Analysis, Gray Literature Search, Systematic Literature Review, Secondary Data Collection

Consulting Scientific and Technical Consulting, Regulatory Consulting

Data & AI Data Processing

Product Development Product Evaluation, Concept Development, Prototyping

職務経験

Independent Consultant

VeNaV Consulting

6月 2021 - 現在

Scientist & Regulatory affairs

IVAG

12月 2019 - 5月 2021

Project Representative in Drug Development

Merck KGaA

1月 2017 - 11月 2019

Scientist

Merck KGaA

1月 2016 - 12月 2016

Post-Doctoral Fellow in Pharmacology

Max Planck Institute of Molecular Physiology

12月 2011 - 7月 2015

PhD Fellow in Drug Discovery

Spanish National Research Council (CSIC)

12月 2006 - 10月 2011

学歴

PhD

University of Barcelona

1月 2007 - 11月 2011

M.Sc (Master of Science)

University of Barcelona

10月 2006 - 1月 2008

Bachelor of Science (B.Sc) Chemistry

Autonomous University of Barcelona

9月 2002 - 6月 2006

認定資格

• Certification on Medical Device Regulation (MDR)

  TüV Süd Akademie

  2月 2020 - 現在

• Pharmacokinetics/Pharmacodynamics (PKPD)

  DMDG

  5月 2019 - 現在

• Clinical Pharmacology: Pharmacokinetics/Pharmacodynamics in Drug development

  RW Biosciences LTD

  11月 2018 - 現在

• Pharmacokinetics basics

  PK Workshops

  7月 2017 - 現在

• Business presentations

  HPS Germany

  10月 2016 - 現在

出版物

JOURNAL ARTICLE

Vendrell-Navarro, G., Scheible, H., Lignet, F., Burt, H., Luepfert, C., Marx, A., Abla, N., Swart, P., Perrin, D.(2020). Insights into Praziquantel Metabolism and Potential Enantiomeric Cytochrome P450–Mediated Drug-Drug Interaction . Drug Metabolism and Disposition. 48. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 481-490.

Villoslada, P., Vila, G., Colafrancesco, V., Moreno, B., Fernandez-Diez, B., Vazquez, R., Pertsovskaya, I., Zubizarreta, I., Pulido-Valdeolivas, I., Messeguer, J., et al.(2019). Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation . Neurotherapeutics. 16. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 808-827.

Schneidewind, T., Kapoor, S., Garivet, G., Karageorgis, G., Narayan, R., Vendrell-Navarro, G., Antonchick, A.P., Ziegler, S., Waldmann, H.(2019). The Pseudo Natural Product Myokinasib Is a Myosin Light Chain Kinase 1 Inhibitor with Unprecedented Chemotype . Cell Chemical Biology. 26. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 512-523.e5.

Vendrell-Navarro, G., Rúa, F., Bujons, J., Brockmeyer, A., Janning, P., Ziegler, S., Messeguer, A., Waldmann, H.(2015). Positional Scanning Synthesis of a Peptoid Library Yields New Inducers of Apoptosis that Target Karyopherins and Tubulin . ChemBioChem. 16. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1580-1587.

Messeguer, J., Cortés, N., García-Sanz, N., Navarro-Vendrell, G., Ferrer-Montiel, A., Messeguer, A.(2008). Synthesis of a positional scanning library of pentamers of N-alkylglycines assisted by microwave activation and validation via the identification of trypsin inhibitors . Journal of Combinatorial Chemistry. 10. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 974-980.

BOOK

Vendrell-Navarro, G., Brockmeyer, A., Waldmann, H., Janning, P., Ziegler, S.(2015). Identification of the targets of biologically active small molecules using quantitative proteomics . Methods in Molecular Biology. 1263. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 263-286.

OTHER

Glòria Vendrell-Navarro, Andreas Brockmeyer, Herbert Waldmann, Petra Janning, Slava Ziegler(2014). Identification of the Targets of Biologically Active Small Molecules Using Quantitative Proteomics . Methods in Molecular Biology. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 263--286. Springer New York

PATENT

Moreno, B.V., P.; Navarro, G.; Messeguer, J.; Messeguer, A., New peptoid agonists of nerve growth factor receptor and their use as medicaments. WO/2011/024079. 2011.

Moreno, B.V., P.; Navarro-Vendrell, G.; Messeguer, J.; Messeguer, A., 3-oxopiperazinium derivatives as agonists of nerve growth factor receptors and their use as medicaments. WO 2011/024078 A1. 2011.